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B-cell epitopes in the nucleocapsid protein (N) of Puumala (PUU) virus were investigated by use of truncated recombinant
proteins and overlapping peptides. Six of seven epitopes, recognized by bank vole monoclonal antibodies, were localized
within the amino-terminal region of the protein (aa 1–79). Polyclonal antibodies from wild-trapped or experimentally infected
bank voles identified epitopes located over the entire protein. Antibody end-point titers to different N fragments indicated
that the amino-terminal region is the major antigenic target in PUU virus-infected bank voles. To investigate the role of PUU
virus N in protective immunity, we analyzed the immunogenicity of truncated recombinant N and developed an animal model
based on colonized bank voles. No PUU virus N antigen, nor any glycoprotein-specific antibodies, could be detected after
virus challenge in animals immunized with an amino-terminal fragment (aa 1–118), a fragment covering two thirds of the
protein (aa 1–267), or total N, indicating that a complete protection was evoked by the recombinant proteins. Two of eight
animals immunized with shorter N fragments displayed either N antigen, or glycoprotein-specific antibodies, suggestive of
partial protection. Prechallenge sera from all groups of immunized animals were found negative or only weakly positive for
neutralizing antibodies when assayed by focus reduction neutralization test, which indicated an important role for cell-
mediated immunity in protection. q 1996 Academic Press, Inc.
INTRODUCTION field mouse (Apodemus agrarius), rats (Rattus norvegicus
and R. rattus) and the bank vole (Clethrionomys glareo-
Hantaviruses, members of the family Bunyaviridae, are lus), respectively, cause clinically similar human dis-
enveloped negative-stranded RNA viruses with tripartite eases, referred to as hemorrhagic fever with renal syn-
genomes (Schmaljohn et al., 1985). The Hantavirus genus drome (HFRS). The diseases are characterized by fever,
is comprised of at least eight serologically and geneti- renal failure, and, in severe cases, hemorrhagic manifes-
cally distinct groups of viruses: Hantaan (HTN), Seoul tations (Yanagihara and Gajdusek, 1988). The clinical
(SEO), Puumala (PUU), Prospect Hill (PH), Dobrava, Thai- manifestations of HFRS are generally most severe for
land, Thottapalayam, and Sin Nombre/Four Corners vi- infections caused by HTN virus, less severe for SEO
ruses (Schmaljohn et al., 1985; Schmaljohn et al., 1995; virus, and milder for PUU virus. The mortality of HFRS
Nichol et al., 1993; Chu et al., 1994; Hjelle et al., 1994a; varies between 0.2 and 10% and approximately 150,000
Xiao et al., 1994). In addition, nucleotide sequence and cases occur annually world wide (for review see Lundk-
immunological data on five potentially new serotype vi- vist and Niklasson, 1994). In 1993, a new hantavirus-
ruses, Tula (TUL) (Plyusnin et al., 1994), El Moro Canyon caused human disease, called hantavirus pulmonary
(Hjelle et al., 1994b), Khabarovsk (Dzagurova et al., 1995; syndrome (HPS), was discovered in the United States
Ho¨rling et al., unpublished observation), Bayou (Morzu- (Nichol et al., 1993). HPS, characterized by acute respira-
nov et al., 1995), and Black Creek Canal (Rollin et al., tory distress, has a mortality of approximately 50%. The
1995) have been reported. Small mammals, mainly ro- etiologic agent of HPS, designated Sin Nombre/Four Cor-
dents, are the natural reservoirs of hantaviruses and ner viruses, are carried primarily by the deer mouse (Per-
transmission to humans occurs via aerosolized animal omyscus maniculatus) (Nichol et al., 1993; Hjelle et al.,
excreta (Elliot, 1990). 1994a; Spiropoulou et al., 1994).
HTN, SEO, and PUU viruses, carried by the striped The genomes of hantaviruses encode four structural
proteins: the L-segment encodes a virus-associated
RNA-dependent RNA polymerase, the M-segment two1 To whom correspondence and reprint requests should be ad-
glycosylated envelope proteins (G1 and G2), and the S-dressed at Department of Defense Microbiology, Swedish Institute for
segment a nucleocapsid protein (N) (Schmaljohn andInfectious Disease Control, S-105 21, Stockholm, Sweden. Fax: /46-
8-7303248. E-mail: Ake.Lundkvist@smi.ki.se. Dalrymple, 1983; Antic et al., 1991). The envelope glyco-
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proteins are presumed to be the major elements involved was passaged in colonized bank voles as previously de-
scribed (Gavrilovskaya et al., 1983).in induction of immunity to hantaviruses, since mono-
clonal antibodies (Mabs) to G1 and G2, but not to the
Antibodiesnucleocapsid protein (N), have been found to neutralize
viral infectivity in vitro (Dantas et al., 1986; Arikawa et al., Generation and characterization of PUU virus N-, G1-,
1989; Lundkvist and Niklasson 1992). The importance of and G2-specific bank vole Mabs have been described
the humoral response for protection against HTN virus elsewhere (Lundkvist et al., 1991; Lundkvist and Niklas-
infection has been demonstrated by passive transfer of son, 1992). Briefly, colonized bank voles were infected
immune sera or Mabs and subsequent challenge with with PUU virus obtained from lung tissues of bank voles
virus (Zhang et al., 1989; Schmaljohn et al., 1990; Arikawa trapped in northern Sweden. [Bank vole 1 mouse] heter-
et al., 1992). A cell-mediated immune response to HTN ohybridomas were established and PUU virus-specific
virus has also been implicated in protection (Asada et clones were selected after screening against native
al., 1988, 1989; Yoshimatsu et al., 1993). The actual impor- virus.
tance and protein specificity of the cellular response has, Large scale Mab production was performed by cultur-
however, not been resolved. Recombinant HTN virus gly- ing hybridomas in roller bottles followed by purification
coproteins, expressed by baculovirus and vaccinia virus on protein-G Sepharose as previously described (Lundk-
vectors, have been shown to protect hamsters from infec- vist et al., 1991). Polyclonal antisera to Keyhole limpet
tion. For complete protection, recombinants expressing hemocyanin (KLH)-conjugated peptides (Berzins et al.,
both G1 and G2 were needed (Schmaljohn et al., 1990). 1986) were raised in bank voles and in Balb/c mice by
Passive transfer of spleen cells from mice immunized three biweekly, subcutaneous (sc) immunizations of 100
with recombinant G1/G2 partially protected suckling mg peptide-conjugate emulsified in Freund’s complete
mice from infection (Yoshimatsu et al., 1993). Interest- adjuvant, Freund’s incomplete adjuvant, and phosphate-
ingly, HTN virus recombinant N (rN) has been shown buffered saline (PBS), respectively.
to protect hamsters and suckling mice from HTN virus
infection (Schmaljohn et al., 1990; Yoshimatsu et al., Peptide P4
1993). Moreover, a Mab specific for HTN N has been
The peptide P4, a 30 amino acid (aa) carboxy-terminalshown to protect mice from infection (Yoshimatsu et al.,
amide corresponding to residues 241–270 (EKECPFIKP-1993).
EVKPGTPAQEIEMLKRNKIYF) of PUU virus N, was syn-We have recently identified B-cell epitopes on the PUU
thesized by Scandinavian Peptide Synthesis (Ko¨ping,virus N recognized by the polyclonal antibody response
Sweden).in humans (Lundkvist et al., 1995a; Vapalahti et al., 1995).
With a panel of PUU virus bank vole Mabs, reactive with
Recombinant PUU virus N proteins
eight distinct epitopes on N, only one epitope could be
defined when overlapping 10-mer amino acid peptides The production of PUU N in insect cells with a recombi-
nant baculovirus (bac-PUU-N) has been described in de-were used (Lundkvist et al., 1995a).
To further define the localization of B-cell epitopes tail elsewhere (Vapalahti et al., 1996). Briefly, the antigen
consisted of an extract of Spodoptera frugiperda (Sf9)recognized by the natural reservoir of PUU virus, the
bank vole, we chose to use longer synthetic peptides cells containing approximately 35% of bac-PUU-N, solubi-
lized with urea, and passed through Sephadex columnsand truncated rN proteins. To investigate the role of PUU
virus N in protective immunity, we analyzed the immuno- into an aqueous buffer with proteinase inhibitors. The
areas coding for truncated N proteins, expressed asgenicity of truncated rN proteins and developed an ani-
mal model. Our results show that several B-cell epitopes GST-fusion proteins in E. coli, were individually amplified
by PCR using the PUU virus Sotkamo strain S cDNAare located in the amino-terminal part of N, and that N
produced in insect cells and as GST-fusion proteins in (Vapalahti et al., 1992) as a template, cut with restric-
tion enzymes and cloned to the BamHI and EcoRI sitesEscherichia coli elicit strong antibody responses and
protect animals from infection with PUU virus. of pGEX2T vector (Pharmacia, Uppsala, Sweden) as fol-
lows: Construct rN 1a coding for aa 1–79 with primers
A: (TTTGAATTCTCTAGATCTGGAATGAGTGACTTGAC-
MATERIALS AND METHODS
AGA) and B: (TTTGAATTCTTGGATCCAGTCGG-
TTAAGTAGGTTTAGTA), construct rN 1b coding for aaVirus strains
1–118 with primers A and C: (TTTGAATTCGTCGACTCA-
ATCTGCTGTTTGGCCACTTG), construct rN 3 coding forPUU virus prototype strain Sotkamo (Brummer-Korven-
kontio et al., 1980; Vapalahti et al., 1992) was propagated aa 229–327 and six extra aa from the polylinker area
with primers D: (TTTGTCGACGGATCCAAGGATTGGTC-in Vero E6 cells (CRL 1586, ATCC) cultivated in Eagle’s
MEM supplemented with 2% fetal calf serum (FCS), 2 TGAGAGAA) and E: (TTTGAATTCGTCGACTCAGCAACA-
TAGATACATGTTGG), construct rN 2b coding for aa 135–mM L-glutamine and antibiotics. PUU virus strain Kazan
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214 with primers F: (TTTGTCGACGGATCCAAAGCTTTA- ELISA. PUU rN fragments, 5 mg/ml in coating buffer (0.05
M carbonate buffer, pH 9.6) of purified proteins or 1:200TACATGTCTC and G: (TTTGAATTCGTCGACTCAGTTA-
GCAACCTGGATCTGAG), construct rN 2c coding for aa dilutions of nonpurified proteins, or nonpurified bac-PUU-
N (diluted 1:1000), were adsorbed to microtiter plates135–327 and six extra aa from the vector with primers
F and E. Extra stop codons and the natural initiation overnight at 47. Unsaturated protein-binding sites were
blocked by addition of 3% bovine serum albumine (BSA)codon of PUU N are underlined, restriction sites used for
cloning are shown in bold. The cloning and expression of in PBS for 1 hr. Serial dilutions of sera in ELISA buffer
(PBS with 0.5% BSA and 0.05% Tween-20) were preincu-constructs rN 2/3 (aa 1–267, GST-PUU-N2/3, Vapalahti
et al., 1995) and rN Tot (total coding area, GST-TUL-N, bated with 1% GST-c for 1 hr before addition to plates.
Adsorbed sera were incubated for 1 hr followed by ALP-Plyusnin et al., 1994) and rN Eco (aa 1–61, GST-TUL-
N-delta) have been described previously. The plasmid conjugated goat anti-mouse IgG and p-nitrophenyl phos-
phatase substrate according to the manufacturer’s in-pGEX2T without an insert coding only for the GST was
used as a control (GST-c). structions (Sigma). All incubations (100 ml/well) were
performed at 377 and plates were washed five times inThe expression of the GST-fusion proteins was per-
formed as recommended by the manufacturer (Phar- washing buffer (0.9% NaCl and 0.05% Tween 20) between
each step. End-point titers were expressed as the recip-macia). Briefly, overnight cultures of transformed BL21
bacteria (Studier et al., 1990) were diluted 1/100 and rocal of the maximum dilution of sera giving a ratio of
3 times that obtained with control antigen.grown for 2 hr at 377, induced with 0.5 mM IPTG for 3 hr
after which the cells were pelleted. GST-fusion proteins To investigate antibody reactivity to the carboxy-termi-
nal of PUU virus N (aa 328–433), bank vole immunewere purified by binding to Glutathione Sepharose 4B
beads (Pharmacia) in the presence of 2% N-lauroylsar- sera were preabsorbed to rN 2/3 and rN 3 (together
corresponding to aa 1–327) before testing for reactivitycosine (Sigma, St. Louis, MO) as described by Frangioni
and Neel (1993). The protein was eluted from the beads to bac-PUU-N (covering total N). Sera (diluted 1:200) were
incubated with a cocktail of rN 2/3 and rN 3 (20 mg/mlby 25 mM reduced glutathione (Boehringer Mannheim,
Mannheim, Germany) and dialyzed. of each protein) for 2 hr at 207.
Immunoblotting
PUU virus G1/G2 ELISA
Bacterial cell suspensions were suspended in
Laemmli’s sample buffer and proteins were separated in Bank vole sera were analyzed for presence of antibod-
ies reactive with the PUU virus envelope glycoproteinsSDS–PAGE and transferred to Immobilon filters (Milli-
pore, Bedford, MA). After blocking, filters were subse- (G1 and G2) by an ELISA. The human Mabs G1-1E7-1E5
and 1C9 (Lundkvist et al., 1993a; 1993b), specific for PUUquently incubated with Mabs (1 mg/ml) overnight at 47,
followed by rabbit anti-mouse peroxidase-conjugate (Da- virus G1 and G2 (epitopes G1-b and G2-a2), respectively,
5 mg/ml in coating buffer, were adsorbed to microtiterkopatts, Denmark), diluted 1:400, for 1 hr at 207. Blots
were visualized by addition of 1-1-diaminobenzidine sub- plates overnight at 47. All the following incubations were
performed for 1 hr at 377 with five washes between eachstrate.
step. Unsaturated protein binding sites were blocked
Epitope mapping (PEPSCAN) with 3% BSA in PBS. Detergent-treated native PUU virus
antigen prepared as previously described (Lundkvist andThe PEPSCAN method (Geysen et al., 1987), designed
for identification of linear B-cell epitopes, was used to Niklasson, 1992) or control antigen (diluent only), fol-
lowed by serial twofold dilutions of sera (starting atlocate antibody-reactive peptides comprised within the
sequence of N of PUU virus prototype strain Sotkamo. 1:200), were added to the plates. ALP-labeled donkey
anti-mouse IgG (Jackson, West Grove, PA), followed byIn total, 141 peptides (14-mer overlapping peptides cov-
ering the complete N by a shift of three amino acids; p-nitrophenyl phosphate substrate (Sigma), were used to
detect specific antibody binding according to the manu-Vapalahti et al., 1995) were examined. Antibody reactivi-
ties with PEPSCAN peptides were measured by ELISA facturer’s instructions. End-point titers were determined
as described above.as previously described (Geysen et al., 1987), using poly-
clonal bank vole sera (diluted 1:200). Bound antibodies The specificity of the assay was examined by Mab
reactivity. Bank vole Mabs 5A2 and 5B7, specific for addi-were detected with alkaline phosphatase (ALP)-conju-
gated goat anti-mouse IgG and p-nitrophenyl phosphate tional G1- and G2-epitopes (G1-a and G2-b), respectively,
and consequently not interactive in the antigen bindingsubstrate according to the manufacturer’s instructions
(Sigma). by the human Mabs used for antigen capture, and the
N-specific Mab 3E11, were conjugated to biotin as de-
PUU virus rN ELISA scribed elsewhere (Harlow and Lane, 1988). Biotinylated
Mabs (0.1 mg/ml) were incubated for 1 hr. Peroxidase-Antibody reactivities of wild-trapped and experimen-
tally infected bank voles to PUU rN were examined by conjugated streptavidin (Sigma), followed by tetrameth-
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which recognize seven distinct antigenic sites on N, and
with polyclonal sera from wild-trapped or experimentally
infected bank voles. When assayed in immunoblotting with
four truncated recombinant PUU virus N-fragments, the six
Mabs 5E1, 5B5, 3G5, 1C12, 2E12, and 4E5 recognized all
fragments covering the amino-terminal region of the pro-
tein, thus identifying six epitopes within the amino-terminal
region (aa 1–79, Fig. 2A, Table 1). When two types of TUL
virus rN proteins were assayed with Mabs that previously
had been found cross-reactive with TUL virus (Plyusnin etFIG. 1. Coommasie blue-stained SDS–PAGE of purified recombinant
PUU N proteins. Lanes contain: (1) GST-c, (2) rN 1a, (3) rN 1b, (4) rN al., 1994), Mab 2E12 recognized rN Tot (aa 1–430) but not
3, (5) bac-PUU-N, (6) rN 2/3. Numbers at the left mark the mobilities rN Eco (aa 1–61), indicating that this Mab reacted with a
of protein molecular mass standards in kilodaltons. region located between aa 62 and 79 (Fig. 2B). A similar
pattern was found for Mab 3G5, although the reactivity
ylbenzidine substrate (Sigma) were used according to with rN Tot was weak. In addition to bac-PUU-N, Mab 3H9
the manufacturer’s instructions to detect specific anti- reacted exclusively with two fragments, rN 2/3 (aa 1–267)
body binding. and rN 3 (aa 229–327), which correlated well with the
previously reported mapping of its epitope (N-a) to aa 251–
Animal immunization and PUU virus challenge 260 (Lundkvist et al., 1995a, Fig. 2C).
To assess immunogenicity as well as protection, 4- to
10-week-old bank voles, derived from a PUU virus-free
colony established several years earlier with animals
captured in Sweden, were immunized with purified trun-
cated PUU virus N-GST fusion proteins, baculovirus PUU
N (bac-PUU-N), or GST-c as a negative control. Bank
voles were injected sc with 50 mg of specific proteins
emulsified in Freund’s complete adjuvant. The second
and third injections were given with 3-week intervals,
using the same amount of proteins in incomplete
Freund’s adjuvant and PBS, respectively. Serum antibody
responses against PUU virus were measured 1 day be-
fore challenge by immunofluorescence assay (IFA;
Lundkvist et al., 1991) and focus reduction neutralization
test (FRNT; Niklasson et al., 1991). Bank voles were chal-
lenged sc 2 weeks after the last injection (8 weeks post-
primary immunization) with 104 ID50 of PUU virus (strain
Kazan). Animals were sacrificed at 21 days post chal-
lenge, and lungs were examined for presence of PUU
virus-specific antigen by Hantavirus antigen-ELISA as
previously described (Lundkvist et al., 1995b).
RESULTS
Expression of truncated recombinant PUU virus N
The GST-fusion proteins rN 1a (aa 1–79), rN 1b (aa
1–118), rN 2b (aa 135–214), rN 2c (aa 135–327), and rN
3 (229–327) were cloned and expressed to high levels
in E. coli. These GST-proteins and an earlier described
construct rN 2/3 (aa 1– 267), used for immunization of
bank voles and in ELISA, were purified with glutathione
sepharose beads in the presence of N-lauroylsarcosine
with moderate to high yields (Fig. 1). FIG. 2. Localization of Mab epitopes using truncated PUU virus N
proteins in immunoblot assays. (A) Mab 5E1, (B) Mab 2E12, (C) Mab
3H9. Lanes contain: (1) bac-PUU-N, (2) Sf9 extract, (3) TUL rN Tot, (4)Epitope mapping with truncated rN fragments
TUL rN Eco, (5) PUU rN 3, (6) PUU rN 2/3, (7) PUU rN 1b, (8) PUU rN
The localization of B-cell epitopes in the N protein of 1a. Numbers at the right mark the mobilities of protein molecular mass
standards in kilodaltons.PUU virus was investigated by a panel of bank vole Mabs,
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TABLE 1
Summary of Mab Reactivity in Immunoblotting with Truncated rN Proteins
Mab
(epitope)
3H9 5E1 5B5 3G5 1C12 2E12 4E5
Antigen (N-a) (N-b) (N-c) (N-d) (N-f) (N-g) (N-h)
PUU virus
rN 1a (1–79) 0a / / / / / /
rN 1b (1–118) 0 / / / / / /
rN 2/3 (1–267) / / / / / / /
rN 3 (229–327) / 0 0 0 0 0 0
bac-PUU-N (1–433) / / / / / / /
Tula virus
rN Eco (1–61) 0 0 0 0 / 0 /
rN Tot (1–430) 0 0 0 (/) / / /
a /, positive reaction; (/), weak reaction; 0, negative.
Pooled polyclonal sera from wild-trapped, PUU virus bac-PUU-N. Although the pooled sera from bac-PUU-N-
immunized animals showed the highest reactivity, signifi-IgG-positive bank voles, from experimentally PUU virus-
infected bank voles, and from bank voles immunized with cant reactions were also seen with the serum pools from
naturally and experimentally infected bank voles, sug-bac-PUU-N were analyzed for IgG reactivity with trun-
cated PUU rN fragments by ELISA (Table 2). The two gesting the presence of B-cell epitopes between aa 328
and 433 (Table 2). No reactivity with the fragments rN 2/sera obtained from infected animals were highly reactive
with the amino-terminal fragments, in contrast to low or 3 and 3 could be detected after the absorption.
no reactivity with the fragments covering aa 135–327.
PEPSCANSerum from animals immunized with bac-PUU-N reacted
equally with all the different fragments except for rN 2b
In total, 141 overlapping 14-mer peptides of PUU virus
(aa 135–214). To examine the reactivity with the carboxy-
(strain Sotkamo), covering the whole N in three-aa shifts,
terminal of N, sera were absorbed with rN 2/3 and 3
were used for epitope mapping using the PEPSCAN
(equivalent to aa 1–327) before testing for reactivity to
method. Several linear B-cell epitopes were identified
over the entire N when a pool of polyclonal antisera,
drawn from experimentally infected bank voles, were an-TABLE 2
alyzed (Fig. 3A). Pooled sera from IgG-positive, wild-
IgG Reactivity of Bank Vole Sera to Truncated
trapped bank voles revealed a similar pattern, althoughPuumala Virus rN Proteins
the reactivity was mainly directed to the first 50% (aa 1–
210) of the protein (Fig. 3B). No unspecific reactivitiesSerum
were seen when a pool of sera from 5 noninfected colo-
PUU PUU nized bank voles were analyzed (Fig. 3C).
Antigen (wild)a (Kazan)b Bac-PUU-Nc Nonimmune
Immunogenicity of rN and synthetic peptidesrN 1a (1–79) 51,200d 51,200 12,800 200
rN 1b (1–118) 12,800 12,800 3,200 200
Sera from bank voles immunized with different rN frag-rN 2/3 (1–267) 51,200 3,200 12,800 200
ments or bac-PUU-N were analyzed for the presence ofrN 2b (135– 214) 200 200 200 200
rN 2c (135–327) 200 200 12,800 200 antibodies to native PUU virus antigen. Pooled sera from
rN 3 (229–327) 200 200 3,200 200 bank voles infected with PUU virus, from noninfected
C-terminale 3,200 800 12,800 200 animals, and from animals immunized with GST-c, were
bac-PUU-N (1–433) 3,200 3,200 12,800 200
used as positive and negative controls, respectively. All
rN fragments, as well as bac-PUU-N, evoked high titersa Pooled sera (n 5) from PUU virus IgG positive bank voles trapped
in northern Sweden. of IgG reactive with native PUU N as determined by IFA.
b Pooled sera (n  5) drawn 3 weeks after experimental infection The result indicated the presence of several distinct im-
with PUU virus strain Kazan. munogenic regions in the protein. The end-point titersc Pooled sera (n  2) from bank voles immunized with bac-PUU-N.
are displayed in Table 3.d Reciprocal end-point ELISA titers.
All except one of the pooled immune sera were founde Sera were preabsorbed with rN 2/3 and rN 3 (together equivalent
to aa 1–327) before titration to bac-PUU-N. negative for neutralizing activity when assayed by FRNT
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Protection of bank voles from infection with PUU
virus
An animal model that mimics the symptoms of PUU
virus infection in humans has not been described. PUU
virus causes a prolonged or persistent infection in bank
voles, with no apparent pathogenicity. However, viral an-
tigen can be detected routinely in selected organs of
naturally or experimentally infected animals. To evaluate
potential protective immune responses to PUU virus
N, we developed a virus challenge model in bank
voles, the major natural reservoir of this virus. We
found that our stock of PUU virus strain Kazan, pas-
saged exclusively in bank voles, infected all animals,
as judged by N antigen detected in lungs, up to a
dilution of 1:106. In contrast, PUU virus strain Sotkamo,
isolated and passaged in Vero E6, did not infect all
animals reproducibly and viral antigen was found only
sporadically. Therefore, for the protection experiments,
animals were challenged with PUU virus strain Kazan
diluted 1:103, equivalent to 104 ID50 .
To evaluate the ability of the recombinant-expressed
PUU virus N proteins to elicit a protective response in
bank voles, the animals were given three immunizations
with each rN protein. Serum antibody titers were mea-
sured after the third immunization (Table 3). Three weeks
after the challenge with PUU virus, the animals were
sacrificed and the lungs examined for the presence of
PUU virus N antigen. None of the bank voles immunized
with the bac-PUU-N preparation or the rN fragments 1a
(aa 1–79), 1b (aa 1–118), and 2/3 (1–267) displayed N
antigen in their lungs after challenge (Table 4). One of
three animals immunized with rN 3 (aa 229–327) dis-
TABLE 3
Immune Responses to Puumala Virus in Bank Voles afterFIG. 3. PEPSCAN analysis of IgG reactivity to 14-mer peptides span-
Immunizations with Authentic, Expressed, or Synthetic Puumala Virus Nning PUU virus N with 3 aa overlap. Each bar displays the antibody
reactivity (OD 1 1000 at 405 nm). (A) Pooled sera (n  5) from experi-
Reciprocal end-point titersmentally infected bank voles, (B) Pooled sera (n  3) from PUU virus-
No. ofimmune bank voles trapped in northern Sweden, (C) Pooled sera (n 
Immunogen animals IFA FRNT G1/G2 ELISA5) from noninfected bank voles.
rN 1a (1–79) 2 6,400 40 200(Table 3). Sera from animals immunized with rN 2/3 neu-
3 3,200 40 200
tralized PUU virus at the lowest dilution (1:40). Sera from rN 1b (1–118) 3 3,200 40 200
bank voles experimentally or naturally infected with PUU rN 2/3 (1–267) 3 1,600 40 200
rN 3 (229–327) 3 3,200 40 200virus showed neutralizing end-point titers of 1280.
bac-PUU-N (1–433) 2 1,600 40 200A 30-aa synthetic peptide (P4, aa 241–270), covering
GST-c 5 100 40 200the Mab epitope N-a (Lundkvist et al., 1995a), located
PUU virus (wild)a 5 1,600 1,280 6,400within a region of N previously defined as a major epitope PUU virus (Kazan)b 5 1,600 1,280 12,800
in the human antibody response to PUU virus infection P4 3 400 40 200
(Vapalahti et al., 1995), was used for immunization of P4-KLH 3 800 40 200
P4-KLH (mice) 3 6,400 40 200bank voles and Balb/C mice. When analyzed by IFA,
Nonimmune control 2 100 40 200pooled sera from bank voles and mice immunized with
P4-KLH conjugate showed high reactivity with native a Sera from PUU virus IgG positive wild bank voles trapped in north-
PUU virus N with end-point titers of 800 and 6400, respec- ern Sweden.
tively. Bank voles immunized with P4 alone (i.e., without b Sera drawn 3 weeks after experimental infection with PUU virus
strain Kazan.KLH-conjugation), raised N-specific IgG as well (titer 400).
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TABLE 4 after challenge. One of five animals immunized with the
short amino-terminal fragment rN 1a (aa 1–79) devel-Challenge of Bank Voles Immunized with
oped glycoprotein-specific antibodies after challenge.Recombinant Puumala Virus N
The absence of N antigen in its lungs, however, sug-
Immunogen Antigen in lungs G1/G2 antibody gested partial protection. One of the animals immunized
with rN 3 (aa 229–327) displayed N antigen in its lungs
rN 1a (1–79) 0/5a 1/5b (12,800)c
and developed high levels of glycoprotein-specific anti-rN 1b (1–118) 0/3 0/3
bodies after challenge. The results showed that immuni-rN 2/3 (1–267) 0/3 0/3
rN 3 (229–327) 1/3 1/3 (⁄25,600) zation with fragments rN 1b or rN 3 may protect some
bac-PUU-N (1–433) 0/8 0/8 animals from infection while not as effectively as immuni-
GST-c 5/5 5/5 (12,800–⁄25,600) zations with larger parts of PUU virus N.
Nonimmune control 8/8 8/8 (6,400–⁄25,600)
a Number of N-antigen positive/number of inoculated. DISCUSSION
b Number of G1/G2-specific antibody positive/number of inoculated.
c Range of titer for all infected animals in each group. The PUU virus nucleocapsid protein was shown to
contain several B-cell epitopes recognized by the bank
vole, the natural reservoir of this hantavirus. Six of seven
played N antigen. All five control animals immunized with previously defined epitopes, recognized by Mabs gener-
GST-c and all eight nonimmunized animals became N ated from a virus-infected bank vole, were mapped within
antigen positive after challenge. the first 20% of the protein (aa 1–79), thereby indicating
In order to confirm our initial observation that the ab- the amino-terminal region of PUU N as a major antigenic
sence of N antigen in lungs of bank voles after viral region. The localization of four Mab-epitopes within aa
challenge indicated protection, post-challenge sera were 1–61, and two between aa 62–79, correlated well with
analyzed. Since IFA detects antibodies reactive with all our earlier mapping data, based on additivity and com-
the different viral structural proteins, and the prechal- petitive ELISAs, together with reactivity patterns with vari-
lenge immunizations elicited high levels of N-reactive ous hantavirus strains, which suggested that several of
antibodies, we developed an ELISA based on human the epitopes were partially or completely overlapping
Mabs for specific detection of bank vole IgG reactive (Lundkvist et al., 1991; Lundkvist and Niklasson, 1992).
with the PUU virus envelope glycoproteins (G1 and G2). Polyclonal sera from naturally or experimentally in-
Protected animals should posses antibodies only to the fected bank voles revealed the presence of B-cell epi-
N protein with which they were immunized, whereas ani- topes over the entire N. Although sera from infected ani-
mals that did become infected would exhibit demonstra- mals were nonreactive with the rN 2 b fragment (aa 135–
ble antibodies also to the viral glycoproteins. The assay 214), PEPSCAN data indicated the presence of antigenic
was proven to detect only antibodies directed to the two domains also within this region. The suggestion that the
PUU virus envelope glycoproteins when the antigen- amino-terminal region constitutes the major antigenic
specificity was evaluated by PUU virus N-, G1-, and G2- target in PUU virus-infected bank voles, as indicated by
specific Mabs. No cross-reaction, due to unspecific bind- the end-point titers to the different N-fragments, is in
ing to the solid-phase of N antigen, was shown with the concordance with the Mab-epitope mapping. In contrast,
N-specific Mab, which demonstrated disassociation of immunizations with complete N (bac-PUU-N) gave rise
the detergent-disrupted and indirectly coated viral com- to similar IgG levels to all different fragments, except rN
ponents. The detection limit of the assay was estimated 2b. Although the PEPSCAN data and the IgG end-point
to be less than 15 ng/ml of bank vole IgG by end-point titers to the different rN fragments correlated to some
titration of pooled G1- and G2-specific Mabs. extent, discrepancies were found. The latter method de-
Individual post-challenge sera were examined for gly- tected reactivities primarily to the amino-terminus, while
coprotein-specific antibodies by the G1/G2 ELISA. All PEPSCAN detected epitopes throughout the protein. This
animals immunized with the amino-terminal fragment rN could be due to several reasons; e.g., the low reactivity
1b (aa 1–118), rN 2/3 (aa 1–267), or total bac-PUU-N, seen with the middle part of N using rN fragments can
and lacking detectable N antigen, were found completely be explained either by epitopes hidden in the protein
negative for glycoprotein-specific antibodies after chal- and/or that these linear epitopes, detected by PEPSCAN,
lenge (Table 4). In contrast, nonimmunized animals or are not properly presented in E. coli-expressed rN. We
animals immunized with GST-c all showed high titers of have previously shown that the epitopes N-a and N-e
glycoprotein-specific antibodies after challenge, as did are not recognized in rN expressed as b-gal-N fusion
PUU virus-immune wild-trapped bank voles (Tables 3 and protein in contrast to the baculovirus recombinant where
4). This confirmed that all animals immunized with pro- all examined N-epitopes were detected (Vapalahti et al.,
teins corresponding to aa 1–118 or larger amino-terminal 1996). N-a, but not N-e, was properly expressed in the
GST fusion-proteins used in this study (data not shown).fragments of PUU N were not infected with PUU virus
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These results suggested that, although highly immuno- in vitro for Mabs directed to G1 and G2, but not to N
(Dantas et al., 1986; Arikawa et al., 1989; Zhang et al.,genic and antigenic domains are present throughout N,
the IgG responses in infected bank voles are mainly 1989; Schmaljohn et al., 1990; Arikawa et al., 1992; Lundk-
vist and Niklasson, 1992). The significance of the N-spe-directed to the amino-terminus. Studies on the human
IgG response to PUU virus N have shown a similar pat- cific antibody response in vivo is, however, not yet com-
pletely understood. A Mab specific for HTN virus N hastern, i.e., data based on truncated N proteins indicated
the amino-terminal part as the major antigenic region been shown to protect from virus infection and N-specific
polyclonal sera to significantly increase the time beforealthough PEPSCAN data revealed the presence of anti-
genic domains also in other parts of the protein (Go¨tt et death in a mouse model (Yoshimatsu et al., 1993). N-
specific Mabs have been shown to partially protect bankal., 1991; Lundkvist et al., 1995a; Vapalahti et al., 1992;
1995; F. Elgh and A˚. Lundkvist, unpublished). Similarly, voles from PUU virus infection (Lundkvist et al., unpub-
lished). Therefore, it is likely that the explanation to theit has been shown for Sin Nombre virus that the major
domain for the humoral reactivity resides within the reported absence of neutralizing activity for all hantavirus
N-specific Mabs, as determined by NT or FRNT, is dueamino-terminus of an E. coli-expressed N protein (Jeni-
son et al., 1994; Yamada et al., 1995). to the use of in vitro systems, which do not necessarily
reflect the situation in vivo. Accordingly, the humoral re-Examination by IFA revealed that all the different rN
fragments elicited significant levels of IgG levels reactive sponse to N may, in addition to the glycoprotein-specific
antibody response, be of importance for the immunity,with native PUU N. The highly immunogenic nature of
the amino-terminal part was further confirmed by the rel- e.g., via antibody-dependent cell-mediated cytotoxity and
complement-mediated cytolysis.atively high antibody titers to native N evoked in animals
immunized with rN 1a (aa 1–79); none of the pooled sera Previous reports have suggested that a cell-mediated
response to HTN virus is involved in protection (Asadaraised to the larger rN fragments or to the entire N (i.e.,
bac-PUU-N or during viral infection) showed higher titers et al., 1988, 1989; Yoshimatsu et al., 1993). Since all ex-
cept one of the pooled prechallenge sera in our experi-to native N. The peptide P4, conjugated to KLH, elicited
high antibody responses to native N both in bank voles ments were found negative for neutralizing antibodies
when assayed by FRNT, the protection, evoked by theand mice. Interestingly, bank voles immunized with P4
alone (i.e., without KLH-conjugation), raised N-specific different regions of PUU virus N, was interpreted as
mainly dependent on cell-mediated immune responses.IgG as well, indicating the presence of at least one spe-
cific T-cell epitope within aa 241–270. Additional information is required to further define the
important aspects of the immunity to PUU virus. Our dataThe absence of known HFRS-like disease in animals
made it impossible to evaluate the ability of our recombi- suggest, regardless of the mechanism(s), that our recom-
binant-expressed N proteins are clearly capable of induc-nant proteins to moderate disease; however, a more
stringent assay for measurement of protection from PUU ing a response that can protect animals from infection
after challenge with high doses of PUU virus.virus infection was developed. As demonstrated by virus
challenge experiments, none of the animals immunized In conclusion, our results revealed the location of sev-
eral B-cell epitopes in PUU virus N and indicated that thewith the amino-terminal fragments or with complete re-
combinant N (bac-PUU-N) displayed N antigen in their amino-terminus is the major antigenic domain in infected
bank voles. Our data further demonstrated the feasibilitylungs even after challenge with 104 ID50 of PUU virus.
When postchallenge sera were analyzed, only one of of using expressed or synthetic fragments of PUU virus
N to elicit high antibody responses to the native proteinthe animals (immunized with the shortest amino-terminal
fragment), did not appear to be completely protected as and indicated the importance of N, especially the amino-
terminus, in the course of protective immunity. This studyjudged by the presence of glycoprotein-specific antibod-
ies. This confirmed that all animals immunized with pro- may also provide a basis for future experiments concern-
ing recombinant-expressed PUU virus proteins as poten-teins corresponding to aa 1–118, or with larger amino-
terminal fragments of PUU N, were completely protected tial human vaccines.
against infection. In line with this, HTN virus recombinant
N has previously been shown to protect hamsters or ACKNOWLEDGMENTS
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